ClinicalTrials.Veeva

Menu

NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.

R

Rennes University Hospital

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: 10% amylose bread
Dietary Supplement: Carbohydrates
Other: 20% amylose bread

Study type

Interventional

Funder types

Other

Identifiers

NCT01437917
2011-A00517-34 (Other Identifier)
11/19-808 (Other Identifier)
LOC/11-05 - NOMAC
B110607-50 (Other Identifier)

Details and patient eligibility

About

The consumption of cereals-based foods with low glycemic indexes, high micronutrients and fibers contents are highly recommended. The target of this work is to provide new solutions for cereal based foods: the knowledge and understanding on the in vivo fate will be used to define structural features to gain in foods.

Enrollment

10 patients

Sex

All

Ages

19 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy individual,
  • Age between 19-65 years
  • With normal food habits with at least 2 main meals per day
  • Non smoking
  • Having filled the consent form

Exclusion criteria

  • BMI > 25 kg/m2,
  • Diabetes or any illness susceptible to alter
  • Coeliac disease
  • Past history of intestinal diseases.
  • Treatment susceptible of modifying glycemia.
  • Allergy

Trial design

10 participants in 3 patient groups

Bread with 20% amylose content
Experimental group
Description:
Bread with 20% amylose content
Treatment:
Other: 20% amylose bread
Bread with 10% amylose content
Experimental group
Description:
Bread with 10% amylose content
Treatment:
Dietary Supplement: 10% amylose bread
carbohydrates
Experimental group
Description:
50g of carbohydrates ingested with 400 ml of water
Treatment:
Dietary Supplement: Carbohydrates

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems